- Home
- CNOB vs STAA Comparison
CNOB vs STAA Comparison
Compare CNOB & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNOB | STAA |
|---|---|---|
| Founded | 1982 | 1982 |
| Country | United States | United States |
| Employees | 756 | N/A |
| Industry | Major Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | CNOB | STAA |
|---|---|---|
| Price | $32.44 | $29.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $31.25 | $22.81 |
| AVG Volume (30 Days) | 348.8K | ★ 640.9K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $42.85 | $30.82 |
| Revenue Next Year | $7.27 | $8.41 |
| P/E Ratio | ★ $17.02 | $288.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.07 | $15.59 |
| 52 Week High | $33.12 | $35.87 |
Technical Indicators
Market Signals| Indicator | CNOB | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 66.10 | 50.23 |
| Support Level | $24.76 | $28.03 |
| Resistance Level | N/A | $31.05 |
| Average True Range (ATR) | 0.76 | 1.00 |
| MACD | 0.12 | -0.28 |
| Stochastic Oscillator | 82.36 | 36.09 |
Price Performance
Historical ComparisonAbout CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets, and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental, and consumer wages.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.